-
1
-
-
33745078633
-
Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion
-
CASCADE Collaboration
-
C. Smit, R. Geskus, S. Walker CASCADE Collaboration Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion AIDS 20 2006 741 749
-
(2006)
AIDS
, vol.20
, pp. 741-749
-
-
Smit, C.1
Geskus, R.2
Walker, S.3
-
2
-
-
33748116898
-
Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study
-
F.J. Palella, R.K. Baker, A.C. Moorman Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study J Acquir Immune Defic Syndr 43 2006 27 34
-
(2006)
J Acquir Immune Defic Syndr
, vol.43
, pp. 27-34
-
-
Palella, F.J.1
Baker, R.K.2
Moorman, A.C.3
-
3
-
-
65449136656
-
Diagnosis, management, and treatment of hepatitis C: An update
-
M.G. Ghany, D.B. Strader, D.L. Thomas Diagnosis, management, and treatment of hepatitis C: an update Hepatology 49 2009 1335 1374
-
(2009)
Hepatology
, vol.49
, pp. 1335-1374
-
-
Ghany, M.G.1
Strader, D.B.2
Thomas, D.L.3
-
4
-
-
53549115066
-
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: A meta-analysis
-
H.H. Thein, Q. Yi, G.J. Dore Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis AIDS 22 2008 1979 1991
-
(2008)
AIDS
, vol.22
, pp. 1979-1991
-
-
Thein, H.H.1
Yi, Q.2
Dore, G.J.3
-
5
-
-
72849116931
-
Meta-analysis: Increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression
-
T.Y. Chen, E.L. Ding, G.R. Seage Iii Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression Clin Infect Dis 49 2009 1605 1615
-
(2009)
Clin Infect Dis
, vol.49
, pp. 1605-1615
-
-
Chen, T.Y.1
Ding, E.L.2
Seage Iii, G.R.3
-
6
-
-
24644443695
-
Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy
-
J.K. Rockstroh, A. Mocroft, V. Soriano Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy J Infect Dis 192 2005 992 1002
-
(2005)
J Infect Dis
, vol.192
, pp. 992-1002
-
-
Rockstroh, J.K.1
Mocroft, A.2
Soriano, V.3
-
7
-
-
84869495977
-
Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy
-
J. Berenguer, B. Alejos, V. Hernando Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy AIDS 26 2012 2241 2246
-
(2012)
AIDS
, vol.26
, pp. 2241-2246
-
-
Berenguer, J.1
Alejos, B.2
Hernando, V.3
-
8
-
-
10244242497
-
The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy
-
M. Dorrucci, C. Valdarchi, B. Suligoi The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy AIDS 18 2004 2313 2318
-
(2004)
AIDS
, vol.18
, pp. 2313-2318
-
-
Dorrucci, M.1
Valdarchi, C.2
Suligoi, B.3
-
9
-
-
8444248309
-
Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database
-
N. Voirin, C. Trépo, P. Miailhes Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database J Viral Hepat 11 2004 559 562
-
(2004)
J Viral Hepat
, vol.11
, pp. 559-562
-
-
Voirin, N.1
Trépo, C.2
Miailhes, P.3
-
10
-
-
0038163753
-
The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy
-
M.B. Klein, R.G. Lalonde, S. Suissa The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy J Acquir Immune Defic Syndr 33 2003 365 372
-
(2003)
J Acquir Immune Defic Syndr
, vol.33
, pp. 365-372
-
-
Klein, M.B.1
Lalonde, R.G.2
Suissa, S.3
-
11
-
-
13244267370
-
Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection
-
C.C. Hung, M.Y. Chen, S.M. Hsieh Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection Int J STD AIDS 16 2005 42 48
-
(2005)
Int J STD AIDS
, vol.16
, pp. 42-48
-
-
Hung, C.C.1
Chen, M.Y.2
Hsieh, S.M.3
-
12
-
-
13544259969
-
Survival in hepatitis C and HIV co-infection: A cohort study of hospitalized veterans
-
H.B. El-Serag, T.P. Giordano, J. Kramer Survival in hepatitis C and HIV co-infection: a cohort study of hospitalized veterans Clin Gastroenterol Hepatol 3 2005 175 183
-
(2005)
Clin Gastroenterol Hepatol
, vol.3
, pp. 175-183
-
-
El-Serag, H.B.1
Giordano, T.P.2
Kramer, J.3
-
13
-
-
0036453090
-
Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy
-
J. Macías, I. Melguizo, F.J. Fernández-Rivera Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy Eur J Clin Microbiol Infect Dis 21 2002 775 781
-
(2002)
Eur J Clin Microbiol Infect Dis
, vol.21
, pp. 775-781
-
-
Macías, J.1
Melguizo, I.2
Fernández-Rivera, F.J.3
-
14
-
-
7944226613
-
An example of nonrandom missing data for hepatitis C virus status in a prognostic study among HIV-infected patients
-
C. Lewden, H. Jacqmin-Gadda, J.L. Vilde An example of nonrandom missing data for hepatitis C virus status in a prognostic study among HIV-infected patients HIV Clin Trials 5 2004 224 231
-
(2004)
HIV Clin Trials
, vol.5
, pp. 224-231
-
-
Lewden, C.1
Jacqmin-Gadda, H.2
Vilde, J.L.3
-
15
-
-
0034305946
-
Changes in the uptake of antiviral therapy and survival in people with known duration of HIV infection in Europe: Results from CASCADE
-
CASCADE Collaboration
-
CASCADE Collaboration Changes in the uptake of antiviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE HIV Med 1 2000 224 231
-
(2000)
HIV Med
, vol.1
, pp. 224-231
-
-
-
16
-
-
80051546683
-
The Coding Causes of Death in HIV (CoDe) Project: Initial results and evaluation of methodology
-
J.D. Kowalska, N. Friis-Moller, O. Kirk The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology Epidemiology 22 2011 516 523
-
(2011)
Epidemiology
, vol.22
, pp. 516-523
-
-
Kowalska, J.D.1
Friis-Moller, N.2
Kirk, O.3
-
17
-
-
85027944119
-
The hepatitis C epidemic among HIV-positive MSM: Incidence estimates from 1990 to 2007
-
J.J. van der Helm, M. Prins, J. del Amo The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007 AIDS 25 2011 1083 1091
-
(2011)
AIDS
, vol.25
, pp. 1083-1091
-
-
Van Der Helm, J.J.1
Prins, M.2
Del Amo, J.3
-
18
-
-
69949108828
-
Imputing missing covariate values for the Cox model
-
I.R. White, P. Royston Imputing missing covariate values for the Cox model Stat Med 28 2009 1982 1998
-
(2009)
Stat Med
, vol.28
, pp. 1982-1998
-
-
White, I.R.1
Royston, P.2
-
22
-
-
34248397713
-
Tutorial in biostatistics: Competing risks and multi-state models
-
2389-2340
-
H. Putter, M. Fiocco, R.B. Geskus Tutorial in biostatistics: competing risks and multi-state models Stat Med 26 2007 2389-2340
-
(2007)
Stat Med
, vol.26
-
-
Putter, H.1
Fiocco, M.2
Geskus, R.B.3
-
23
-
-
78650235570
-
Cause-specific cumulative incidence estimation and the Fine and Gray model under both left truncation and right censoring
-
R.B. Geskus Cause-specific cumulative incidence estimation and the Fine and Gray model under both left truncation and right censoring Biometrics 67 2011 39 49
-
(2011)
Biometrics
, vol.67
, pp. 39-49
-
-
Geskus, R.B.1
-
24
-
-
70149113077
-
-
R development Core Team R Foundation for Statistical Computing Vienna, Austria Accessed December 17, 2012
-
R development Core Team R: a language and environment for statistical computing 2009 R Foundation for Statistical Computing Vienna, Austria http://www.R-project.org Accessed December 17, 2012
-
(2009)
R: A Language and Environment for Statistical Computing
-
-
-
25
-
-
77955553749
-
The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models
-
L.C. de Wreede, M. Fiocco, H. Putter The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models Comput Methods Programs Biomed 99 2010 261 274
-
(2010)
Comput Methods Programs Biomed
, vol.99
, pp. 261-274
-
-
De Wreede, L.C.1
Fiocco, M.2
Putter, H.3
-
26
-
-
0034715950
-
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The Swiss HIV Cohort Study
-
G. Greub, B. Ledergerber, M. Battegay Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study Lancet 356 2000 1800 1805
-
(2000)
Lancet
, vol.356
, pp. 1800-1805
-
-
Greub, G.1
Ledergerber, B.2
Battegay, M.3
-
27
-
-
0037055011
-
Hepatitis C and progression of HIV disease
-
M.S. Sulkowski, R.D. Moore, S.H. Mehta Hepatitis C and progression of HIV disease JAMA 288 2002 199 206
-
(2002)
JAMA
, vol.288
, pp. 199-206
-
-
Sulkowski, M.S.1
Moore, R.D.2
Mehta, S.H.3
-
28
-
-
79952705520
-
HIV/HCV co-infection: Pathogenesis, clinical complications, treatment, and new therapeutic technologies
-
E.A. Operskalski, A. Kovacs HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies Curr HIV/AIDS Rep 8 2011 12 22
-
(2011)
Curr HIV/AIDS Rep
, vol.8
, pp. 12-22
-
-
Operskalski, E.A.1
Kovacs, A.2
-
29
-
-
80054948562
-
HIV and hepatitis C co-infection: The role of HAART in HIV/hepatitis C virus management
-
M. Jones, M. Nunez HIV and hepatitis C co-infection: the role of HAART in HIV/hepatitis C virus management Curr Opin HIV AIDS 6 2011 546 552
-
(2011)
Curr Opin HIV AIDS
, vol.6
, pp. 546-552
-
-
Jones, M.1
Nunez, M.2
-
30
-
-
2942567897
-
Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort
-
W.P. Law, C.J. Duncombe, A. Mahanontharit Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort AIDS 18 2004 1169 1177
-
(2004)
AIDS
, vol.18
, pp. 1169-1177
-
-
Law, W.P.1
Duncombe, C.J.2
Mahanontharit, A.3
-
31
-
-
84862572786
-
Impact of hepatitis C co-infection on response to antiretroviral treatment
-
F. Pulido, A. Hill, Y. van Delft Impact of hepatitis C co-infection on response to antiretroviral treatment AIDS Rev 14 2012 124 131
-
(2012)
AIDS Rev
, vol.14
, pp. 124-131
-
-
Pulido, F.1
Hill, A.2
Van Delft, Y.3
-
32
-
-
80052959049
-
Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting
-
T. Reiberger, M. Obermeier, B.A. Payer Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting Antivir Ther 16 2011 815 824
-
(2011)
Antivir Ther
, vol.16
, pp. 815-824
-
-
Reiberger, T.1
Obermeier, M.2
Payer, B.A.3
-
33
-
-
67651083226
-
Hepatitis C treatment for injection drug users: A review of the available evidence
-
M. Hellard, R. Sacks-Davis, J. Gold Hepatitis C treatment for injection drug users: a review of the available evidence Clin Infect Dis 49 2009 561 573
-
(2009)
Clin Infect Dis
, vol.49
, pp. 561-573
-
-
Hellard, M.1
Sacks-Davis, R.2
Gold, J.3
-
34
-
-
34548709023
-
Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy
-
J.A. Pineda, J.A. Garcia-Garcia, M. Aguilar-Guisado Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy Hepatology 46 2007 622 630
-
(2007)
Hepatology
, vol.46
, pp. 622-630
-
-
Pineda, J.A.1
Garcia-Garcia, J.A.2
Aguilar-Guisado, M.3
-
35
-
-
12244293401
-
Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients
-
C. Tural, D. Fuster, J. Tor Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients J Viral Hepat 10 2003 118 125
-
(2003)
J Viral Hepat
, vol.10
, pp. 118-125
-
-
Tural, C.1
Fuster, D.2
Tor, J.3
-
36
-
-
0344120830
-
Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection
-
N. Qurishi, C. Kreuzberg, G. Luchters Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection Lancet 362 2003 1708 1713
-
(2003)
Lancet
, vol.362
, pp. 1708-1713
-
-
Qurishi, N.1
Kreuzberg, C.2
Luchters, G.3
-
37
-
-
79960453276
-
Clinical Practice Guidelines: Management of hepatitis C virus infection
-
European Association for the Study of the Liver
-
European Association for the Study of the Liver Clinical Practice Guidelines: management of hepatitis C virus infection J Hepatol 55 2011 245 264
-
(2011)
J Hepatol
, vol.55
, pp. 245-264
-
-
-
38
-
-
79959360426
-
Influence of antiretroviral therapy on liver disease
-
H. Kovari, R. Weber Influence of antiretroviral therapy on liver disease Curr Opin HIV AIDS 6 2011 272 277
-
(2011)
Curr Opin HIV AIDS
, vol.6
, pp. 272-277
-
-
Kovari, H.1
Weber, R.2
-
39
-
-
80855137985
-
Challenges and opportunities for hepatitis C drug development in HIV-HCV coinfected patients
-
V. Soriano, K.E. Sherman, J. Rockstroh Challenges and opportunities for hepatitis C drug development in HIV-HCV coinfected patients AIDS 25 2011 2197 2208
-
(2011)
AIDS
, vol.25
, pp. 2197-2208
-
-
Soriano, V.1
Sherman, K.E.2
Rockstroh, J.3
-
40
-
-
80054963278
-
HIV and hepatitis C co-infection: Acute HCV therapy
-
C. Boesecke, M. Vogel HIV and hepatitis C co-infection: acute HCV therapy Curr Opin HIV AIDS 6 2011 459 464
-
(2011)
Curr Opin HIV AIDS
, vol.6
, pp. 459-464
-
-
Boesecke, C.1
Vogel, M.2
-
41
-
-
0037079352
-
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
-
C.L. Thio, E.C. Seaberg, R. Skolasky HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) Lancet 360 2002 1921 1926
-
(2002)
Lancet
, vol.360
, pp. 1921-1926
-
-
Thio, C.L.1
Seaberg, E.C.2
Skolasky, R.3
-
42
-
-
78349262304
-
CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era
-
S. Lodi, A. Phillips, G. Touloumi CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era AIDS 24 2010 2697 2704
-
(2010)
AIDS
, vol.24
, pp. 2697-2704
-
-
Lodi, S.1
Phillips, A.2
Touloumi, G.3
-
43
-
-
50649116552
-
Gender differences in HIV progression to AIDS and death in industrialized countries: Slower disease progression following HIV seroconversion in women
-
I. Jarrin, R. Geskus, K. Bhaskaran Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women Am J Epidemiol 168 2008 532 540
-
(2008)
Am J Epidemiol
, vol.168
, pp. 532-540
-
-
Jarrin, I.1
Geskus, R.2
Bhaskaran, K.3
|